Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 10/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | FBP1 | P09467 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8869636 | 1.00 | NFE2L2 (0.46) | NFE2L2PTGS1PTGS2NQO2CACNA1B | |
| SCHEMBL8718906 | 0.85 | PTGS1 (0.34) | PTGS1PTGS2 | |
| SCHEMBL8718911 | 0.85 | PTGS1 (0.34) | PTGS1PTGS2 | |
| SCHEMBL8715248 | 0.82 | PTGS1 (0.39) | NFE2L2PTGS1PTGS2MEN1KMT2A | |
| SCHEMBL8715251 | 0.82 | PTGS1 (0.39) | NFE2L2PTGS1PTGS2MEN1KMT2A | |
| SCHEMBL8718561 | 0.82 | IDO1 (0.49) | CACNA1BMEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL8718564 | 0.82 | IDO1 (0.49) | CACNA1BMEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL8715226 | 0.78 | NFE2L2 (0.49) | NFE2L2CACNA1BMEN1KMT2AMAPT | |
| SCHEMBL8715224 | 0.78 | NFE2L2 (0.49) | NFE2L2CACNA1BMEN1KMT2AMAPT | |
| SCHEMBL28462555 | 0.78 | NFE2L2 (0.53) | NFE2L2PTGS1PTGS2NQO2CACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5693648-A | TREATMENT OF AUTOIMMUNE DISEASES, INFECTIOUS DISEASES, PREVENTING REJECTION OF ORGAN TRANSPLANTS | MERCK & CO., INC. (US) | 1997-12-02 | — | — | US | disclosed |
| US-5565560-A | TREATING AUTOIMMUNE DISEASES, PREVENTING TRANSPLANT REJECTION | MERCK & CO., INC. (US) | 1996-10-15 | — | — | US | disclosed |
| US-5532248-A | O-aryl,O-alkyl, and O-alkenyl-macrolides having immunosuppressive activity | MERCK CO., INC. (US) | 1996-07-02 | — | — | US | disclosed |
| EP-0515071-A2 | O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity | MERCK & CO. INC. (US) | 1992-11-25 | — | — | EP | disclosed |